sanofi-aventis spins out Novexel

Aventis Pharma, a subsidiary of sanofi-aventis (Euronext:SAN; SNY), spun out infectious disease

Read the full 123 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE